---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-112826"
form_type: "8-K"
ticker: "IDXX"
cik: "0000874716"
company_name: "IDEXX LABORATORIES INC /DE"
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:52:09.607868+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# IDEXX Q3 EPS $2.80, revenue $976M; cuts FY24 revenue guidance citing macro headwinds

## Summary
- Q3 revenue $976M (+7% reported, +6% organic); EPS $2.80 (+11% reported, +12% comparable).
- CAG Diagnostics recurring revenue +7% reported and organic; global premium instrument installed base +10% YoY.
- FY24 revenue guidance cut $38M at midpoint to $3,865M-$3,890M; organic growth now 5.3%-6.0% (prior 6.2%-7.8%).
- EPS guidance narrowed to $10.37-$10.53, midpoint unchanged; $0.56 negative impact from litigation accrual.
- Water revenue +13%; LPD -3%. Gross margin 61.1% (+120 bps). Operating margin 31.2% (+110 bps).

## SEC filing metadata
- accession: 0001104659-24-112826
- form_type: 8-K
- ticker: IDXX
- cik: 0000874716
- company_name: IDEXX LABORATORIES INC /DE
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/874716/000110465924112826/0001104659-24-112826-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/874716/000110465924112826/tm2427157d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-112826
- JSON: https://secwatch.observer/filing/0001104659-24-112826.json
- Plain text: https://secwatch.observer/filing/0001104659-24-112826.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.